A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trial.
Saved in:
| Title: | A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trial. |
|---|---|
| Authors: | Shibuya, Kazumoto1 (AUTHOR), Misawa, Sonoko1 (AUTHOR), Kimura, Hideki2 (AUTHOR), Noto, Yu-Ichi3 (AUTHOR), Sato, Yasunori4 (AUTHOR), Sekiguchi, Yukari1 (AUTHOR), Iwai, Yuta1 (AUTHOR), Mitsuma, Satsuki1 (AUTHOR), Beppu, Minako1 (AUTHOR), Watanabe, Keisuke1 (AUTHOR), Fujimaki, Yumi2 (AUTHOR), Tsuji, Yukiko3 (AUTHOR), Shimizu, Toshio2 (AUTHOR), Mizuno, Toshiki3 (AUTHOR), Nakagawa, Masanori3 (AUTHOR), Sawaguchi, Kyoko4 (AUTHOR), Hanaoka, Hideki4 (AUTHOR), Kuwabara, Satoshi1 (AUTHOR) kuwabara-s@faculty.chiba-u.jp |
| Source: | Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. Sep2015, Vol. 16 Issue 5/6, p353-358. 6p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
